These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM. Yokota I; Shirakawa N; Shima K; Matsuda J; Naito E; Ito M; Kuroda Y Diabetes Care; 1996 Jan; 19(1):74-5. PubMed ID: 8720540 [No Abstract] [Full Text] [Related]
7. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950 [TBL] [Abstract][Full Text] [Related]
8. Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM. Kobayashi T; Yabe S; Kikuchi T; Kanda T; Kobayashi I Diabetes Care; 1997 May; 20(5):864-6. PubMed ID: 9135957 [TBL] [Abstract][Full Text] [Related]
9. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus. Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321 [TBL] [Abstract][Full Text] [Related]
11. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy. Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590 [No Abstract] [Full Text] [Related]
12. Antibodies to GAD in elderly patients with previously diagnosed NIDDM. Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369 [No Abstract] [Full Text] [Related]
13. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Lindholm E; Hallengren B; Agardh CD Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992 [TBL] [Abstract][Full Text] [Related]
14. Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children? Kordonouri O; Danne T; Weber B Diabetes Care; 1996 Aug; 19(8):901-2. PubMed ID: 8842617 [No Abstract] [Full Text] [Related]
15. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. Beischer NA; Wein P; Sheedy MT; Mackay IR; Rowley MJ; Zimmet P Am J Obstet Gynecol; 1995 Nov; 173(5):1563-9. PubMed ID: 7503202 [TBL] [Abstract][Full Text] [Related]